ReP USP - Resultado da busca

Artigo de periodico
From your nose to your toes: A review of severe acute respiratory Syndrome Coronavirus 2 Pandemic‒Associated Pernio (2021)
Arkin, Lisa M. ; Moon, John J. ; Tran, Jennifer M. ; Asgari, Samira ; O\2019Farrelly, Cliona ; Casanova, Jean-Laurent ; Cowen, Edward W. ; Mays, Jacqueline W. ; Singh, Anne Marie ; Drolet, Beth A. ; Condino Neto, Antonio
Source: Journal of Investigative Dermatology. Unidade: ICB
Subjects: IMUNOLOGIA, PANDEMIAS, CORONAVIRUS, IMUNIDADE NATURAL, REAÇÃO EM CADEIA POR POLIMERASE, DOENÇAS RESPIRATÓRIAS, INTERFERON TIPO I, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARKIN, Lisa M. et al. From your nose to your toes: A review of severe acute respiratory Syndrome Coronavirus 2 Pandemic‒Associated Pernio. Journal of Investigative Dermatology, p. 1-6, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jid.2021.05.024. Acesso em: 11 nov. 2024.
APA
Arkin, L. M., Moon, J. J., Tran, J. M., Asgari, S., O\2019Farrelly, C., Casanova, J. -L., et al. (2021). From your nose to your toes: A review of severe acute respiratory Syndrome Coronavirus 2 Pandemic‒Associated Pernio. Journal of Investigative Dermatology, 1-6. doi:10.1016/j.jid.2021.05.024
NLM
Arkin LM, Moon JJ, Tran JM, Asgari S, O\2019Farrelly C, Casanova J-L, Cowen EW, Mays JW, Singh AM, Drolet BA, Condino Neto A. From your nose to your toes: A review of severe acute respiratory Syndrome Coronavirus 2 Pandemic‒Associated Pernio [Internet]. Journal of Investigative Dermatology. 2021 ; 1-6.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.jid.2021.05.024
Vancouver
Arkin LM, Moon JJ, Tran JM, Asgari S, O\2019Farrelly C, Casanova J-L, Cowen EW, Mays JW, Singh AM, Drolet BA, Condino Neto A. From your nose to your toes: A review of severe acute respiratory Syndrome Coronavirus 2 Pandemic‒Associated Pernio [Internet]. Journal of Investigative Dermatology. 2021 ; 1-6.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.jid.2021.05.024
Artigo de periodico-carta/editorial
Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection (2021)
Andreakos, Evangelos ; Abel, Laurent ; Vinh, Donald C. ; Kaja, Elzbieta ; Drolet, Beth A. ; Zhang, Qian ; O\2019Farrelly, Cliona ; Novelli, Giuseppe ; Gallego, Carlos Rodríguez ; Haerynck, Filomeen ; Prando, Carolina ; Pujol, Aurora ; Condino Neto, Antonio ; Su, Helen C. ; Casanova, Jean-Laurent ; Spaan, András N. ; Zatz, Mayana
Source: Nature Immunology. Unidades: ICB, IB
Subjects: IMUNOLOGIA, INFECÇÕES POR CORONAVIRUS, CORONAVIRUS, GENÉTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDREAKOS, Evangelos et al. Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1038/s41590-021-01096-9. Acesso em: 11 nov. 2024. , 2021
APA
Andreakos, E., Abel, L., Vinh, D. C., Kaja, E., Drolet, B. A., Zhang, Q., et al. (2021). Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology. New York: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1038/s41590-021-01096-9
NLM
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Su HC, Casanova J-L, Spaan AN, Zatz M. Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ;1 .[citado 2024 nov. 11 ] Available from: https://doi.org/10.1038/s41590-021-01096-9
Vancouver
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Su HC, Casanova J-L, Spaan AN, Zatz M. Author Correction: a global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ;1 .[citado 2024 nov. 11 ] Available from: https://doi.org/10.1038/s41590-021-01096-9
Artigo de periodico
A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection (2021)
Andreakos, Evangelos ; Abel, Laurent ; Vinh, Donald C. ; Kaja, Elzbieta ; Drolet, Beth A. ; Zhang, Qian ; O\2019Farrelly, Cliona ; Novelli, Giuseppe ; Gallego, Carlos Rodríguez ; Haerynck, Filomeen ; Prando, Carolina ; Pujol, Aurora ; Condino Neto, Antonio ; Zatz, Mayana
Source: Nature Immunology. Unidades: ICB, IB
Subjects: IMUNOLOGIA, INFECÇÕES POR CORONAVIRUS, GENÉTICA MÉDICA, INTERFERON TIPO I, QUIMIOCINAS, PLASMODIUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDREAKOS, Evangelos et al. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology, p. 1-6, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41590-021-01030-z. Acesso em: 11 nov. 2024.
APA
Andreakos, E., Abel, L., Vinh, D. C., Kaja, E., Drolet, B. A., Zhang, Q., et al. (2021). A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature Immunology, 1-6. doi:10.1038/s41590-021-01030-z
NLM
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Zatz M. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ; 1-6.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1038/s41590-021-01030-z
Vancouver
Andreakos E, Abel L, Vinh DC, Kaja E, Drolet BA, Zhang Q, O\2019Farrelly C, Novelli G, Gallego CR, Haerynck F, Prando C, Pujol A, Condino Neto A, Zatz M. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection [Internet]. Nature Immunology. 2021 ; 1-6.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1038/s41590-021-01030-z
Artigo de periodico
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021)
Bastard, Paul ; Gervais, Adrian ; Voyer, Tom Le ; Rosain, Jérémie ; Philippot, Quentin; Manry, Jérémy ; Michailidis, Eleftherios ; Hoffmann, Hans-Heinrich ; Eto, Shohei; Garcia-Prat, Marina; Bizien, Lucy; Parra-Martínez, Alba; Yang, Rui; Liis, Haljasmägi; Migaud, Mélanie; Särekannu, Karita; Maslovskaja, Julia; Prost, Nicolas de; Tandjaoui-Lambiotte, Yacine; Luyt , Charles-Edouard; Amador-Borrero, Blanca; Alexandre, Gaudet; Poissy, Julien; Morel, Pascal; Richard, Pascale; Cognasse, Fabrice; Troya, Jesus; Trouillet-Assant, Sophie; Belot, Alexandre; Saker, Kahina; Garçon, Pierre; Rivière, Jacques G; Lagier, Jean-Christophe; Gentile, Stéphanie; Rosen, Lindsey B; Shaw, Elana; Morio, Tomohiro; Tanaka, Junko; Dalmau, David; Tharaux, Pierre-Louis; Sene, Damien; Stepanian, Alain; Megarbane, Bruno; Triantafyllia, Vasiliki; Fekkar, Arnaud; Heath, James R; Franco, José Luis; Anaya, Juan-Manuel; Solé-Violán, Jordi; Imberti, Luisa; Biondi, Andrea; Bonfanti, Paolo; Castagnoli, Riccardo; Delmonte, Ottavia M; Zhang, Yu; Snow, Andrew L; Holland, Steven M; Biggs, Catherine M; Moncada-Vélez, Marcela; Arias, Andrés Augusto; Lorenzo, Lazaro; Boucherit, Soraya; Coulibaly, Boubacar; Anglicheau, Dany; Planas, Anna M; Haerynck, Filomeen; Duvlis, Sotirija; Nussbaum, Robert L; Ozcelik, Tayfun; Keles, Sevgi; Bousfiha, Ahmed A; ElBakkouri, Jalila; Ramirez-Santana, Carolina; Paul, Stéphane; Pan-Hammarström, Qiang; Hammarström, Lennart; Dupont, Annabelle; Kurolap, Alina; Metz, Christine N; Aiuti, Alessandro; Casari, Giorgio; Lampasona, Vito; Ciceri, Fabio; Barreiros, Lucila A; Dominguez-Garrido, Elena; Vidigal, Mateus; Zatz, Mayana ; Beek, Diederik van de; Sahanic, Sabina; Tancevski, Ivan; Stepanovskyy, Yurii; Boyarchuk, Oksana; Nukui, Yoko; Tsumura, Miyuki; Vidaur, Loreto; Tangye, Stuart G; Burrel, Sonia; Duffy, Darragh; Quintana-Murci, Lluis; Klocperk, Adam; Kann, Nelli Y; Shcherbina, Anna; Lau, Yu-Lung; Leung, Daniel; Coulongeat, Matthieu; Marlet, Julien; Koning, Rutger; Reyes, Luis Felipe; Chauvineau-Grenier, Angélique; Vene, Fabienne; Monneret, Guillaume; Nussenzweig, Michel C; Arrestier, Romain; Boudhabhay, Idris; Baris-Feldman, Hagit; Hagin, David; Wauters, Joost; Meyts, Isabelle; Dyer, Adam H; Kennelly, Sean P; Bourke, Nollaig M; Halwani, Rabih; Sharif-Askari, Narjes Saheb; Dorgham, Karim; Sallette, Jérome; Sedkaoui, Souad Mehlal; AlKhater, Suzan; Rigo-Bonnin, Raúl; Morandeira, Francisco; Roussel, Lucie; Vinh, Donald C; Ostrowski, Sisse Rye; Condino Neto, Antonio ; Prando, Carolina ; Bondarenko, Anastasiia; Spaan, András N; Gilardin, Laurent; Fellay, Jacques; Lyonnet, Stanislas; Bilguvar, Kaya; Lifton, Richard P; Mane, Shrikant; Anderson, Mark S; Boisson, Bertrand; Béziat, Vivien; Zhang, Shen-Ying; Andreakos, Evangelos; Hermine, Olivier; Pujol, Aurora; Peterson, Pärt; Mogensen, Trine; H Rowen, Lee; Mond, James; Debette, Stéphanie; Lamballerie, Xavier de; Duval, Xavier; Mentré, France; Zins, Marie; Soler-Palacin, Pere; Colobran, Roger; Gorochov, Guy; Solanich, Xavier; Susen, Sophie; Martinez-Picado, Javier; Raoult, Didier; Vasse, Marc; Gregersen, Peter K; Piemonti, Lorenzo; Rodríguez-Gallego, Carlos; Notarangelo, Luigi D; Su, Helen C; Kisand, Kai; Okada, Satoshi; Puel, Anne; Jouanguy, Emmanuelle; Rice, Charles M; Tiberghien, Pierre; Zhang, Qian; Cobat, Aurélie; Abel, Laurent; Casanova, Jean-Laurent
Source: Science Immunology. Unidades: IB, ICB
Subjects: COVID-19, INFECÇÕES POR CORONAVIRUS, ANTICORPOS, IMUNOLOGIA, HOMENS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASTARD, Paul et al. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, v. 6, n. 62, p. 1-30, 2021Tradução . . Disponível em: https://doi.org/10.1126/sciimmunol.abl4340. Acesso em: 11 nov. 2024.
APA
Bastard, P., Gervais, A., Voyer, T. L., Rosain, J., Philippot, Q., Manry, J., et al. (2021). Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths. Science Immunology, 6( 62), 1-30. doi:10.1126/sciimmunol.abl4340
NLM
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Vancouver
Bastard P, Gervais A, Voyer TL, Rosain J, Philippot Q, Manry J, Michailidis E, Hoffmann H-H, Eto S, Garcia-Prat M, Bizien L, Parra-Martínez A, Yang R, Liis H, Migaud M, Särekannu K, Maslovskaja J, Prost N de, Tandjaoui-Lambiotte Y, Luyt C-E, Amador-Borrero B, Alexandre G, Poissy J, Morel P, Richard P, Cognasse F, Troya J, Trouillet-Assant S, Belot A, Saker K, Garçon P, Rivière JG, Lagier J-C, Gentile S, Rosen LB, Shaw E, Morio T, Tanaka J, Dalmau D, Tharaux P-L, Sene D, Stepanian A, Megarbane B, Triantafyllia V, Fekkar A, Heath JR, Franco JL, Anaya J-M, Solé-Violán J, Imberti L, Biondi A, Bonfanti P, Castagnoli R, Delmonte OM, Zhang Y, Snow AL, Holland SM, Biggs CM, Moncada-Vélez M, Arias AA, Lorenzo L, Boucherit S, Coulibaly B, Anglicheau D, Planas AM, Haerynck F, Duvlis S, Nussbaum RL, Ozcelik T, Keles S, Bousfiha AA, ElBakkouri J, Ramirez-Santana C, Paul S, Pan-Hammarström Q, Hammarström L, Dupont A, Kurolap A, Metz CN, Aiuti A, Casari G, Lampasona V, Ciceri F, Barreiros LA, Dominguez-Garrido E, Vidigal M, Zatz M, Beek D van de, Sahanic S, Tancevski I, Stepanovskyy Y, Boyarchuk O, Nukui Y, Tsumura M, Vidaur L, Tangye SG, Burrel S, Duffy D, Quintana-Murci L, Klocperk A, Kann NY, Shcherbina A, Lau Y-L, Leung D, Coulongeat M, Marlet J, Koning R, Reyes LF, Chauvineau-Grenier A, Vene F, Monneret G, Nussenzweig MC, Arrestier R, Boudhabhay I, Baris-Feldman H, Hagin D, Wauters J, Meyts I, Dyer AH, Kennelly SP, Bourke NM, Halwani R, Sharif-Askari NS, Dorgham K, Sallette J, Sedkaoui SM, AlKhater S, Rigo-Bonnin R, Morandeira F, Roussel L, Vinh DC, Ostrowski SR, Condino Neto A, Prando C, Bondarenko A, Spaan AN, Gilardin L, Fellay J, Lyonnet S, Bilguvar K, Lifton RP, Mane S, Anderson MS, Boisson B, Béziat V, Zhang S-Y, Andreakos E, Hermine O, Pujol A, Peterson P, Mogensen T, H Rowen L, Mond J, Debette S, Lamballerie X de, Duval X, Mentré F, Zins M, Soler-Palacin P, Colobran R, Gorochov G, Solanich X, Susen S, Martinez-Picado J, Raoult D, Vasse M, Gregersen PK, Piemonti L, Rodríguez-Gallego C, Notarangelo LD, Su HC, Kisand K, Okada S, Puel A, Jouanguy E, Rice CM, Tiberghien P, Zhang Q, Cobat A, Abel L, Casanova J-L. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths [Internet]. Science Immunology. 2021 ; 6( 62): 1-30.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1126/sciimmunol.abl4340
Artigo de periodico
Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis (2017)
Nascimento, Ivan Pereira; Rodriguez, Dúnia; Santos, Carina Carvalho dos; Amaral, Eduardo Pinheiro; Rofatto, Henrique Krambeck; Junqueira-Kipnis, Ana Paula; Gonçalves, Eduardo Dantas Casillo; Lima, Maria Regina D'Império ; Hirata, Mario Hiroyuki ; Silva, Célio Lopes; Winter, Nathalie; Gicquel, Brigitte; Mills, Kingston H G; Pizza, Mariagrazia; Rappuoli, Rino; Leite, Luciana C. C
Source: Scientific Reports. Unidades: ICB, FCF, FMRP
Subjects: IMUNOLOGIA, TUBERCULOSE, MYCOBACTERIUM TUBERCULOSIS, ADJUVANTES IMUNOLÓGICOS, PROTEÍNAS RECOMBINANTES, VACINAS, CITOCININAS, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Ivan Pereira et al. Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis. Scientific Reports, v. 7, n. 1, p. 1-11, 2017Tradução . . Disponível em: https://doi.org/10.1038/s41598-017-02003-9. Acesso em: 11 nov. 2024.
APA
Nascimento, I. P., Rodriguez, D., Santos, C. C. dos, Amaral, E. P., Rofatto, H. K., Junqueira-Kipnis, A. P., et al. (2017). Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis. Scientific Reports, 7( 1), 1-11. doi:10.1038/s41598-017-02003-9
NLM
Nascimento IP, Rodriguez D, Santos CC dos, Amaral EP, Rofatto HK, Junqueira-Kipnis AP, Gonçalves EDC, Lima MRD'I, Hirata MH, Silva CL, Winter N, Gicquel B, Mills KHG, Pizza M, Rappuoli R, Leite LCC. Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis [Internet]. Scientific Reports. 2017 ; 7( 1): 1-11.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1038/s41598-017-02003-9
Vancouver
Nascimento IP, Rodriguez D, Santos CC dos, Amaral EP, Rofatto HK, Junqueira-Kipnis AP, Gonçalves EDC, Lima MRD'I, Hirata MH, Silva CL, Winter N, Gicquel B, Mills KHG, Pizza M, Rappuoli R, Leite LCC. Recombinant BCG expressing LTAK63 adjuvant induces superior protection against Mycobacterium tuberculosis [Internet]. Scientific Reports. 2017 ; 7( 1): 1-11.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1038/s41598-017-02003-9

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration